Meaning
neurodevelopmental impairment
SECONDARY, HYPOXIC ISCHEMIC ENCEPHALOPATHY
These findings suggest that circulating biomarkers may improve projection of 2-year outcomes for newborns with hypoxic ischemic encephalopathy.This secondary analysis of a randomized clinical trial develops and evaluates a panel of circulating biomarkers to improve the projection of 2-year neurodevelopmental impairment among neonates with hypoxic ischemic encephalopathy.